ARTICLE | Clinical News
GSK2857916: Ph I BMA117159 data
December 9, 2016 12:03 AM UTC
Data from 30 patients with relapsed or refractory MM in the dose-escalation portion of the open-label, international Phase I BMA117159 trial showed that 0.03 to 4.6 mg/kg doses of IV GSK2857916 every ...
BCIQ Company Profiles